FDA Approves First Generic Single-Dose Flu Treatment

The U.S. Food and Drug Administration has approved the initial generic version of baloxavir marboxil. This single-dose tablet treats acute uncomplicated influenza and offers post-exposure prophylaxis for individuals aged five and above. This approval marks a significant step, enhancing patient access to a crucial antiviral drug.